Quantum BioPharma Statistics
Total Valuation
QNTM has a market cap or net worth of $28.75 million. The enterprise value is $25.19 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
QNTM has 2.80 million shares outstanding. The number of shares has increased by 86.67% in one year.
| Current Share Class | 2.80M |
| Shares Outstanding | 2.80M |
| Shares Change (YoY) | +86.67% |
| Shares Change (QoQ) | +115.92% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.35 |
| P/TBV Ratio | 31.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.28.
| Current Ratio | 0.96 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -46.54 |
Financial Efficiency
Return on equity (ROE) is -268.81% and return on invested capital (ROIC) is -120.32%.
| Return on Equity (ROE) | -268.81% |
| Return on Assets (ROA) | -71.24% |
| Return on Invested Capital (ROIC) | -120.32% |
| Return on Capital Employed (ROCE) | -381.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.23M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.55% in the last 52 weeks. The beta is 0.85, so QNTM's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -51.55% |
| 50-Day Moving Average | 7.01 |
| 200-Day Moving Average | 5.49 |
| Relative Strength Index (RSI) | 68.31 |
| Average Volume (20 Days) | 111,653 |
Short Selling Information
The latest short interest is 107,012, so 3.82% of the outstanding shares have been sold short.
| Short Interest | 107,012 |
| Short Previous Month | 111,766 |
| Short % of Shares Out | 3.82% |
| Short % of Float | 4.55% |
| Short Ratio (days to cover) | 0.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.28M |
| Pretax Income | n/a |
| Net Income | -20.88M |
| EBITDA | -16.78M |
| EBIT | -17.28M |
| Earnings Per Share (EPS) | n/a |
Full Income StatementBalance Sheet
The company has $3.54 million in cash and $1.28 million in debt, giving a net cash position of $2.26 million or $0.81 per share.
| Cash & Cash Equivalents | 3.54M |
| Total Debt | 1.28M |
| Net Cash | 2.26M |
| Net Cash Per Share | $0.81 |
| Equity (Book Value) | 4.53M |
| Book Value Per Share | n/a |
| Working Capital | -412,582 |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.16M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.88M |
| FCF Per Share | -$2.45 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |